At LogiPharma USA 2026, Cold Chain Technologies' TJ Rizzo explains how gaps in end-to-end cold chain expertise create risk ...
Octapharma USA's Kerem Tokel explains how tariffs and DSCSA are affecting how stolen pharma loads are resold, and why partner ...
At LogiPharma USA 2026, the keynote panel on building a truly end-to-end supply chain centered on a familiar industry problem ...
Please check back later for more content.
Global Benchmark for Efficient Drug Pricing (GLOBE) Model, CMS's most favored nation (MFN) pricing policy for Medicare Part B ...
According to Nitin Jayakrishnan, co-founder and CEO of Freehand, disruptions that pharmaceutical supply chains once treated ...
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation. According to Garrett Freeman, sales ...
Identify the risks of layering AI onto legacy supply chain systems, including data fragmentation, hallucinations, and limited auditability in GxP environments. Describe how end-to-end ...
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results